Keyphrases
Histone Deacetylase Inhibitor (HDACi)
100%
Tumor Homing
100%
Folic Acid
100%
Structure-activity Relationship
100%
Design Activity
100%
Pteroic Acid
100%
Solid Tumors
42%
Folate Receptor
42%
Hydroxamate
28%
Novel Therapeutics
14%
Cancer Cells
14%
Cytotoxicity
14%
Cardiotoxicity
14%
Antiproliferative Activity
14%
Adverse Events
14%
Delivery Efficiency
14%
Cutaneous T-cell Lymphoma
14%
Pathological Conditions
14%
Histone Deacetylase 1 (HDAC1)
14%
Therapeutic Index
14%
Targeted Delivery
14%
Recognition Group
14%
Vorinostat
14%
Benzamide
14%
Surface Recognition
14%
Romidepsin
14%
Folate Receptor Expression
14%
Pharmacology, Toxicology and Pharmaceutical Science
Structure Activity Relationship
100%
Histone Deacetylase Inhibitor
100%
Neoplasm
100%
Folate Receptor
66%
Solid Malignant Neoplasm
50%
Malignant Neoplasm
33%
Hydroxamic Acid
33%
Cardiotoxicity
16%
Antiproliferative Activity
16%
Receptor
16%
Adverse Event
16%
Cutaneous T Cell Lymphoma
16%
Histone Deacetylase 1
16%
Vorinostat
16%
Benzamide
16%
Romidepsin
16%
Therapeutic Window
16%
Histone Deacetylase
16%
Cytotoxicity
16%